Xeinadin announces third acquisition of the year    

Kenneth Easby

Date:

Category:

Share this article:

Xeinadin has announced the acquisition of North Yorkshire based accountancy firm, Kenneth Easby Limited. 

Kenneth Easby Limited was founded in 1949 in Bedale, North Yorkshire, and provides a range of financial and business support services to owner-managed businesses, the agricultural sector and high-net-worth individuals. The firm has two offices in Bedale and Northallerton and has a reputation for high-quality tax advice. The firm is led by Ken Graham who will continue to manage the practice under the new Xeinadin ownership. 

The acquisition is the third announcement of an acquisition made by the firm this year and highlights the sustained success in achieving the firm’s long-term growth strategy. In 2023, Xeinadin also acquired Clear Vision Financial Management and Poppleton and Appleby, expanding the firm’s national footprint as well as its expertise whilst maintaining its focus on being the most trusted advisor and supporting owner-managed businesses. 

Xeinadin is a firm of business advisory and accountancy practices in over 130 locations across the UK and Ireland that provides over 40 service lines to over 60,000 clients, predominantly small and medium-sized businesses and their owner-managers. A fast-growing, acquisitive firm, it is one of the professional services market’s leading disrupters.  

Derry Crowley, CEO, Xeinadin, said: “We are pleased to have Kenneth Easby Limited join Xeinadin. The firm is renowned for the quality of its work and is focused on the core customer groups which we are. We are delighted to be working with Ken and the team.”   

Ken Graham, said: “We are pleased to be part of Xeinadin. Being part of a larger firm with the same ethos and focus as our own will not only benefit our customers through offering additional services but also our employees as we have wider resources and knowledge sharing at our fingertips.” 

Latest blogs

Nothing was found here.

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

If you opt for acceptance, we will place all cookies. If you opt for rejection, we will only place functional and analytical cookies. You can adjust your preferences at a later time.

Accept Reject More options

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

Functional cookies
Arrow down

Functional cookies are essential for the proper functioning of our website. They allow us to enable basic functions such as page navigation and access to secure areas. These cookies do not collect personal information and cannot be disabled.

Analytical cookies
Arrow down

Analytical cookies help us gain insight into how visitors use our website. We collect anonymised data about page interactions and navigation, enabling us to continuously improve our site.

Marketing cookies
Arrow down

Marketing cookies are used to track visitors when they visit different websites. The goal is to display relevant advertisements to the individual user. By allowing these cookies, you help us show you relevant content and offers.

Accept all Save

Name

Subtitle
Developer
Location
They are focussed on creating a future-focused and relationship-driven culture, that keeps its promises to you, our team members, and partners.
Xeinadin
has context menu has context menu